(DMAC) - FDA

(DMAC) – FDA

Jun 21, 2023 08:15 AM DiaMedica Therapeutics Inc. (DMAC) Announces that the FDA Has Removed The Clinical Hold On DM199 Phase 2/3 Trial For Ischemic Stroke
Oct 26, 2022 04:30 PM DiaMedica Therapeutics (DMAC) Issues Update on Paused ReMEDy2 Trial
Jul 6, 2022 04:42 PM
Jul 6, 2022 04:35 PM
Oct 18, 2021 08:32 AM
Sep 30, 2021 08:45 AM
Jun 29, 2021 07:06 AM
May 17, 2021 08:54 AM
Dec 10, 2020 08:04 AM
Sep 14, 2020 09:35 AM
May 13, 2020 04:41 PM
Dec 17, 2019 04:15 PM
Oct 14, 2019 07:48 AM
Jun 19, 2019 04:12 PM